OpenVSafe by OpenVAERS
Search V-safe

DMK-30699-16680

4 vaccinations 9 coded responses 31 check-ins 9 free-text entries 3 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
212 / MD
Registered
2021-01-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-16
    Registered in v-safe
  3. 2021-01-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Axillary pain — Feeling: Good · Site: Pain
    Free text: Sore arm pits
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-21
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-28
    Survey response — day 14, dose 1
    MedDRA: Unevaluable event, Vision blurred — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Increased blurry vision. Not sure if its related or not. · Healthcare visit (other): Eye dr appointment scheduled for next week
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-28
    Report sent to call center — day 14, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-02-04
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-10
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-10
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Flatulence — Feeling: Good · Site: Pain · Headache, Muscle or body aches
    Free text: Gas
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Palpitations — Feeling: Fair · Headache
    Free text: Racing heart
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-17
    Survey response — day 35, dose 2
    MedDRA: Headache, Paranasal sinus discomfort — Feeling: Fair
    Free text: Headache, sinus pressure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-27
  24. 2021-10-01
    Dose 3 — Pfizer-BioNTech
  25. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Abdominal pain
    Adult check-in
  26. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-10
    Health check-in — day 7, dose 3
    Feeling: Good · Joint pains
    Adult check-in
  29. 2021-10-16
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-01-02
    Survey response — 3 months, dose 3
    MedDRA: Dermatitis, Rash — Feeling: Fair
    Free text: Skin rashes and inflammation
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-04-08
    Dose 4 — Pfizer-BioNTech
  32. 2022-04-18
    Health check-in — day 7, dose 4
    Feeling: Good · Joint pains
    Adult check-in
  33. 2022-04-22
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-04-30
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-05-06
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-05-14
    Survey response — day 35, dose 4
    MedDRA: Condition aggravated, Joint stiffness, Pre-existing disease — Feeling: Good
    Free text: Not sure if it's related but I continue to have more joint stiffness than I did pre-booster. In retrospect, I feel like I also had a flare of joint stiffness after my fall booster.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-05-20
    Survey response — day 42, dose 4
    MedDRA: Arthralgia, Joint stiffness, Neuropathy peripheral — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Joint stiffness, pain and neuropathy
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-05-20
    Report sent to call center — day 42, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  39. 2022-05-23
  40. 2022-05-24
    Call successful
    Participant prefers to complete VAERS report online
  41. 2022-05-24
    Call successful
    Participant prefers to complete VAERS report online
  42. 2022-07-09
    Survey response — 3 months, dose 4
    MedDRA: COVID-19 — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-07-09
    Report sent to call center — 3 months, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  44. 2022-07-12
  45. 2022-07-12
  46. 2022-07-12

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Pfizer-BioNTech
22021-02-10Pfizer-BioNTech
32021-10-01Pfizer-BioNTech No
42022-04-08Pfizer-BioNTech No

Call center

3 call center cases

2 successful · 1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-16

Systemic reaction (other): Sore arm pits

Release 2 — day 14, dose 1

2021-01-28

Symptoms: Increased blurry vision. Not sure if its related or not.
Healthcare visit (other): Eye dr appointment scheduled for next week

Release 4 — days 1–6 daily, dose 2

2021-02-11

Systemic reaction (other): Gas

2021-02-15

Systemic reaction (other): Racing heart

Release 5 — day 35, dose 2

2021-03-17

Symptoms: Headache, sinus pressure

Release 10 — 3 months, dose 3

2022-01-02

Symptoms: Skin rashes and inflammation

Release 11 — day 35, dose 4

2022-05-14

Symptoms: Not sure if it's related but I continue to have more joint stiffness than I did pre-booster. In retrospect, I feel like I also had a flare of joint stiffness after my fall booster.

Release 11 — day 42, dose 4

2022-05-20

Symptoms: Joint stiffness, pain and neuropathy

Release 12 — 3 months, dose 4

2022-07-09

Symptoms: COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDArthralgia · · ✓
SDCondition aggravated · · ✓
SDCOVID-19 · · ✓
SDDermatitis · · ✓
SDHeadache ✓ ✓ ✓
SDJoint stiffness · · ✓
SDNeuropathy peripheral · · ✓
SDParanasal sinus discomfort ✓ ✓ ✓
SDPre-existing disease · · ✓
SDRash · · ✓
SDVision blurred ✓ ✓ ✓
SROAxillary pain ✓ ✓ ✓
SROFlatulence ✓ ✓ ✓
SROPalpitations ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release